Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
ResMed Inc., a company involved in the healthcare industry, focuses on the development and manufacturing of equipment related to sleep disorders and respiratory care. The recent filing indicates a transaction involving the sale of common stock by Michael J. Rider, Global General Counsel and Secretary, under a pre-established Rule 10b5-1 plan. This transaction reflects changes in beneficial ownership and may have implications for the company’s stock market activities.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$37.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,168,424
Technical Sentiment Signal: Buy
Current Market Cap: A$57.14B
See more insights into RMD stock on TipRanks’ Stock Analysis page.